H1N1 News and Research

RSS
Novel influenza A (H1N1) is a new flu virus of swine origin that was first detected in Mexico and the United States in March and April, 2009. The first novel H1N1 patient in the United States was confirmed by laboratory testing at CDC on April 15, 2009. The second patient was confirmed on April 17, 2009. It was quickly determined that the virus was spreading from person-to-person. On April 22, CDC activated its Emergency Operations Center to better coordinate the public health response. On April 26, 2009, the United States Government declared a public health emergency.

It’s thought that novel influenza A (H1N1) flu spreads in the same way that regular seasonal influenza viruses spread; mainly through the coughs and sneezes of people who are sick with the virus.
Could mRNA vaccines triumph over other viral infections in humans and domestic animals?

Could mRNA vaccines triumph over other viral infections in humans and domestic animals?

Human case of swine-origin influenza A virus detected in Denmark, according to CDC study

Human case of swine-origin influenza A virus detected in Denmark, according to CDC study

WHO releases new data on worldwide influenza activity

WHO releases new data on worldwide influenza activity

Research sheds light on cardiac pathology mechanisms of COVID-19

Research sheds light on cardiac pathology mechanisms of COVID-19

Hemagglutinin stem immunogens may hold the key for broad protection against influenza A viruses

Hemagglutinin stem immunogens may hold the key for broad protection against influenza A viruses

Coronavirus exposure reduction strategies in aircraft cabins involving vacant middle seats and masks

Coronavirus exposure reduction strategies in aircraft cabins involving vacant middle seats and masks

Skipping methotrexate for one week after flu vaccine provides the same seroprotection as a two-week hold in RA patients

Skipping methotrexate for one week after flu vaccine provides the same seroprotection as a two-week hold in RA patients

Influenza hospitalizations at highest level in ten years, predicting a severe U.S. flu season

Influenza hospitalizations at highest level in ten years, predicting a severe U.S. flu season

Hybrid virus particles formed from coinfections exhibit immune evasion and expanded tropism

Hybrid virus particles formed from coinfections exhibit immune evasion and expanded tropism

A review of emerging pediatric respiratory viruses

A review of emerging pediatric respiratory viruses

Exploring molecular docking and molecular dynamics simulations as advanced tools for novel antiviral drug discovery

Exploring molecular docking and molecular dynamics simulations as advanced tools for novel antiviral drug discovery

Inhalation therapeutics against COVID-19

Inhalation therapeutics against COVID-19

Innovative approaches needed to improve flu vaccine effectiveness, experts say

Innovative approaches needed to improve flu vaccine effectiveness, experts say

Intranasal vaccine represents an effective broad-spectrum COVID-19 vaccine strategy

Intranasal vaccine represents an effective broad-spectrum COVID-19 vaccine strategy

What is the vaccine efficacy of repeated influenza vaccinations?

What is the vaccine efficacy of repeated influenza vaccinations?

Specific N-glycans regulate the development and functional maturation of SARS-CoV-2 spike protein

Specific N-glycans regulate the development and functional maturation of SARS-CoV-2 spike protein

What is the efficacy of bioelectronic masks for the detection of respiratory infectious diseases like COVID-19?

What is the efficacy of bioelectronic masks for the detection of respiratory infectious diseases like COVID-19?

Highly sensitive mask can detect respiratory viruses in the air within 10 minutes

Highly sensitive mask can detect respiratory viruses in the air within 10 minutes

Genomic sequencing reveals the course of COVID-19 in Africa

Genomic sequencing reveals the course of COVID-19 in Africa

Bivalent recombinant vaccine protects against SARS-CoV-2 and influenza in animal models

Bivalent recombinant vaccine protects against SARS-CoV-2 and influenza in animal models